Blackstone Inc. closed its latest life-sciences fund with $6.3 billion of commitments, the firm’s biggest haul for backing ...
One of the world’s leading investment firms has broken its own record with the closing of its $6.3 billion Blackstone Life ...
North Carolina’s reputation as a leading state for life sciences is well-known, both in the United States and globally. But ...
HONG KONG SAR - Media OutReach Newswire - 31 March 2026 - Sequencio Therapeutics Company Limited ("Sequencio"), a subsidiary ...
Blackstone (NYSE: BX) today announced the final close of Blackstone Life Sciences VI ("BXLS VI"). BXLS VI was oversubscribed ...
Wave Life Sciences (WVE) stock plunges as the company interim data from an early-stage trial for WVE-007, its RNA-based ...
Wave Life Sciences (NASDAQ:WVE) shares are trading near historic lows after two Wall Street firms cut their price targets ...
W hile challenges persist in the short term, there are signs pointing toward long-term growth for life sciences, according to JLL’s 2024 Life Sciences Real Estate Perspective and Cluster Analysis. The ...
Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of ...
Read about the new Biocom Octane partnership. Discover how this collaboration expands capital and accelerator access for ...
Dr. Mark Turco "will step down" from his role with the Hub Wednesday, March 11, to lead a medical device company.
Barchart on MSN
Wave Life Sciences crashes deep into oversold territory as obesity drug data disappoints. Should you buy the dip?
Wave Life Sciences (WVE) shares crashed more than 50% on Mardh 26 after the company’s interim Phase 1 data for its obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results